Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLID.L Regulatory News (LID)

  • There is currently no data for LID

LiDCO Extends Collaboration With BD

16 Apr 2009 07:00

RNS Number : 6366Q
LiDCO Group Plc
15 April 2009
 



Press Release 

16 April 2009

LiDCO Group Plc

("LiDCO" or "the Company")

LiDCO extends collaboration with BD

LiDCO Group Plc (AIM: LID), the cardiovascular monitoring company, today has extended its exclusive collaboration with BD (Becton, Dickinson and Company)a leading global medical technology company dedicated to helping all people live healthy lives (see www.bd.com).

In June 2007, LiDCO signed an exclusive UK marketing collaboration with Becton, Dickinson U.K. LimitedLiDCO today announces the expansion of this exclusive collaboration with BD. Under the amended and restated terms of the agreement, LiDCO and BD will extend their exclusive marketing collaboration to include additional territories. The collaboration provides that BD Medical - Medical Surgical Systems regional sales teams will provide sales and marketing support for LiDCO products in territories additional to the UK. This marketing collaboration will result in an enhanced product offering for BD's customers as well as superior sales coverage for both LiDCO and LiDCO's network of distributors. 

In a separate agreement, LiDCO have entered an exclusive distribution and sales relationship for the LiDCOrapid Monitor with BD in Japan. This relationship will result in an enhanced product offering for BD customers, as well as improved access to LiDCO's technology by Japanese clinicians and patients. 

Dr Terry O'Brien, Chief Executive of LiDCO, commenting on the agreements stated: "This licensing arrangement in Japan and expansion of our marketing collaboration with a major corporation of the stature of BD further enhances our capabilities to provide our acute care customers with the best possible products and services to improve outcomes and reduce complications such as infections. We are very pleased to share a commitment with BD towards expanding access to innovative technologies that improve outcomes in the critically ill." 

Hideyuki Ashikaga, President, BD in Japan stated:

"BD designs and markets innovative products that address significant healthcare problems and deliver demonstrably higher benefits to patients, healthcare workers and researchers. Collaborating with LiDCO, an innovative company in an important healthcare market, will reinforce our capabilities to serve that market, in line with our corporate purpose of 'Helping all people live healthy lives'".

- ENDS -

For more information please contact:

LiDCO Group Plc

Terry O'Brien - Chief Executive

John Rowland - Company Secretary

Tel: +44 (0)20 7749 1500

www.lidco.com

FinnCap

Geoff Nash/ Stephen Norcross/

Marc Young 

+44 (0)20 7600 1658

www.finncap.com 

Media enquiries

Abchurch Communications

Heather Salmond / Stephanie Cuthbert / Simone Alves 

+44 (0)20 7398 7728

www.abchurch-group.com

About LiDCO Group Plc

LiDCO is a leading supplier of minimally invasive hemodynamic monitoring equipment and disposables. These are used primarily for the management of hospital patients requiring critical care or at major cardiovascular risk. LiDCO's computer-based technology significantly reduces the complications (particularly infections) and costs associated with major surgery. The technology was invented in the Department of Applied Physiology based at St Thomas' Hospital, London. LiDCO is based in the UK and its shares are traded on AIM. For more information please see www.lidco.com.

The Company's manufacturing facility is in Hoxton, London, and its current products are:

* LiDCOplus is a computer-based platform monitor used in the Intensive Care Unit for real-time continuous display of hemodynamic parameters including cardiac output, oxygen delivery and fluid-volume responsiveness (PPV% and SVV%)

* LiDCOrapid: our new cardiac output monitor designed specifically for use in the Operating Theatre for fluid and drug management at the point of care. The monitor features many clinical benefits. These enable acute-care physicians to get accurate and immediate feedback on the patient's fluid and hemodynamic status - a key measure of overall well-being during and after surgery. 

Early and rapid warning of change

Clear indication of therapeutic route: fluid or drug

Quantification of hemodynamic response, particularly stroke volume

Permits more effective delivery of fluids - the right amount at the right time

Advanced hemodynamic care has been shown to:

- Contribute to reduced morbidity and complications

- Reduce length of stay

- Reduce overall cost of care

* LiDCO single-patient-use disposables used in conjunction with the LiDCOplus and LiDCOrapid Monitors. 

LiDCOview: an easy-to-use graphical display of historical LiDCOplus hemodynamic data. Both clinical researchers and routine users can view beat-to-beat hemodynamic data collected with the LiDCOplus. LiDCOviewSE is the standard version of this tool and is available for free, allowing anyone to download and access data from the LiDCOplus. LiDCOviewPRO is the Professional version, allowing users to analyse, export and report the LiDCOplus data. A free trial of LiDCOviewPRO is available for evaluation purposes prior to purchase

LiDCO Distribution Network:

The Company sells direct to hospitals in the UK, and elsewhere predominantly through a worldwide network of specialty critical care and anesthesia distributors.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCIAMFTMMJBBML
Date   Source Headline
5th Dec 20077:00 amPRNClinical Study Results
16th Nov 20077:00 amPRNPlacing of Shares
30th Oct 20077:00 amPRNInterim Results
29th Aug 20077:00 amPRNTrading Statement
15th Aug 20073:11 pmPRNAIM Rule 26
31st Jul 200712:45 pmPRNDirector/PDMR Shareholding
17th Jul 20077:00 amPRNAnnual Report and Accounts
28th Jun 20079:35 amPRNDirector/PDMR Shareholding
25th Jun 20075:14 pmPRNGrant of Options
22nd Jun 200710:45 amPRNAGM Result
21st Jun 20077:00 amPRNTrading Update & AGM Statement
20th Jun 20077:00 amPRNUS Patent Grant
14th Jun 20078:57 amRNSHolding(s) in Company
7th Jun 20077:00 amPRNBD Collaboration
9th May 20077:00 amPRNApproval of Products in South Korea
24th Apr 20073:10 pmPRNNotice of AGM
19th Apr 20077:00 amPRNPreliminary Results
29th Mar 20077:00 amPRNClinical Study Data
26th Mar 20077:00 amPRNNotice of Results & AGM
21st Mar 20077:00 amPRNRelease of LiDCOlive
20th Mar 20072:28 pmRNSHolding(s) in Company
20th Mar 20071:56 pmRNSHolding(s) in Company
20th Mar 200712:55 pmRNSHolding(s) in Company
19th Mar 20074:33 pmRNSHolding(s) in Company
19th Mar 20073:22 pmPRNDirector/PDMR Shareholding
19th Mar 20073:21 pmPRNDirector/PDMR Shareholding
16th Mar 20074:54 pmRNSHolding(s) in Company
23rd Feb 20077:00 amPRNTrading Update
1st Feb 20074:11 pmPRNVoting Rights & Capital
26th Jan 20074:47 pmPRNAdditional Listing
23rd Jan 20077:00 amPRNPediatric Study
22nd Jan 20075:48 pmPRNDirectorate Change
15th Dec 200610:31 amPRNTotal Voting Rights
28th Nov 20067:00 amPRNTrading Update
18th Oct 20067:00 amPRNInterim Results
9th Oct 20062:00 pmPRNNew Software
3rd Oct 20067:00 amPRNR & D Day
25th Sep 20067:00 amPRNShare Listing
19th Sep 20067:00 amPRNContract Extension
22nd Aug 20067:00 amPRNTrading Update
25th Jul 20065:53 pmPRNDirector/PDMR Shareholding
23rd Jun 20064:51 pmPRNGrant of Options
6th Jun 20067:00 amPRNProduct Registration in Switzerland
23rd May 20064:10 pmPRNResult of EGM
28th Apr 200612:58 pmPRNPlacing
28th Apr 200612:57 pmPRNFinal Results
25th Apr 20066:20 pmPRNChange of results day
25th Apr 20067:00 amPRNSoftware Link with Picis
28th Mar 20067:00 amPRNAward Win
14th Feb 20067:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.